Development, Vol 121, Issue 7 2187-2197, Copyright © 1995 by Company of Biologists

JOURNAL ARTICLES

Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein

AL Gard, MR Burrell, SE Pfeiffer, JS Rudge and WC Williams
Department of Structural and Cellular Biology, College of Medicine, University of South Alabama, Mobile 36688, USA.

Programmed death and the identification of growth factors delaying this process in the oligodendrocyte lineage suggest that other cell types provide oligodendrogliotrophins. To determine their source, primary cultures of oligodendroblasts immunopurified from postnatal rat cerebrum were used to screen other cultured neural and non-neural cell types for the release of survival factors into a defined insulin-containing medium. In non-conditioned medium, oligodendroblasts died 1-2 days after undergoing terminal differentiation into oligodendrocytes, as defined by the onset of expression of galactocerebroside. In medium conditioned by astrocytes, unlike the other tested cell types, differentiated oligodendrocytes survived for weeks in a mature myelinogenic state. Survival was partially reduced by immunoabsorption of the medium with antibodies to platelet-derived growth factor and abolished by immunoabsorption with antibodies to leukemia inhibitory factor. By the same criterion, survival activity was not attributed to other astrocytic products, ciliary neurotrophic factor and basic fibroblast growth factor. Membrane ultrafiltration analysis indicated the activity corresponded to heat-labile protein smaller (M(r) = 10(-30) x 10(3)) than native rat leukemia inhibitory factor (M(r) = 43 x 10(3)). The astrocytic stimulus was > 4-fold more efficacious than other known oligodendrogliotrophic cytokines, including ciliary neurotrophic factor, neurotrophin-3 and leukemia inhibitory factor itself, tested singly or in combination, and promoted survival additively with these agents. These findings suggest that astrocytes function as paracrine regulators of oligodendroblast and oligodendrocyte survival and that their effect is mediated initially by platelet-derived growth factor and thereafter by a powerful cytokine related to leukemia inhibitory factor.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A. Gadea, A. Aguirre, T. F. Haydar, and V. Gallo Endothelin-1 Regulates Oligodendrocyte Development J. Neurosci., August 12, 2009; 29(32): 10047 - 10062. [Abstract] [Full Text] [PDF]

				Y. Zhang, C. Taveggia, C. Melendez-Vasquez, S. Einheber, C. S. Raine, J. L. Salzer, C. F. Brosnan, and G. R. John Interleukin-11 Potentiates Oligodendrocyte Survival and Maturation, and Myelin Formation. J. Neurosci., November 22, 2006; 26(47): 12174 - 12185. [Abstract] [Full Text] [PDF]

				L. K. Bekar, M. E. Loewen, K. Cao, X. Sun, J. Leis, R. Wang, G. W. Forsyth, and W. Walz Complex Expression and Localization of Inactivating Kv Channels in Cultured Hippocampal Astrocytes J Neurophysiol, March 1, 2005; 93(3): 1699 - 1709. [Abstract] [Full Text] [PDF]

				E. Molina-Holgado, J. M. Vela, A. Arevalo-Martin, G. Almazan, F. Molina-Holgado, J. Borrell, and C. Guaza Cannabinoids Promote Oligodendrocyte Progenitor Survival: Involvement of Cannabinoid Receptors and Phosphatidylinositol-3 Kinase/Akt Signaling J. Neurosci., November 15, 2002; 22(22): 9742 - 9753. [Abstract] [Full Text] [PDF]

				T. Shimazaki, T. Shingo, and S. Weiss The Ciliary Neurotrophic Factor/Leukemia Inhibitory Factor/gp130 Receptor Complex Operates in the Maintenance of Mammalian Forebrain Neural Stem Cells J. Neurosci., October 1, 2001; 21(19): 7642 - 7653. [Abstract] [Full Text] [PDF]

				O. Dammann and A. Leviton Brain Damage in Preterm Newborns: Might Enhancement of Developmentally Regulated Endogenous Protection Open a Door for Prevention? Pediatrics, September 1, 1999; 104(3): 541 - 550. [Abstract] [Full Text] [PDF]

				K. J. Chandross, R. I. Cohen, P. Paras Jr, M. Gravel, P. E. Braun, and L. D. Hudson Identification and Characterization of Early Glial Progenitors Using a Transgenic Selection Strategy J. Neurosci., January 15, 1999; 19(2): 759 - 774. [Abstract] [Full Text] [PDF]

				R. Marmur, J. A. Kessler, G. Zhu, S. Gokhan, and M. F. Mehler Differentiation of Oligodendroglial Progenitors Derived from Cortical Multipotent Cells Requires Extrinsic Signals Including Activation of gp130/LIFbeta Receptors J. Neurosci., December 1, 1998; 18(23): 9800 - 9811. [Abstract] [Full Text] [PDF]

				D. J. Osterhout, S. Ebner, J. Xu, D. M. Ornitz, G. A. Zazanis, and R. D. McKinnon Transplanted Oligodendrocyte Progenitor Cells Expressing a Dominant-Negative FGF Receptor Transgene Fail to Migrate In Vivo J. Neurosci., December 1, 1997; 17(23): 9122 - 9132. [Abstract] [Full Text] [PDF]

				H. d. F Webster Growth factors and myelin regeneration in multiple sclerosis Multiple Sclerosis, April 1, 1997; 3(2): 113 - 120. [Abstract] [PDF]

				R. I. Cohen, R. Marmur, W. T. Norton, M. F. Mehler, and J. A. Kessler Nerve Growth Factor and Neurotrophin-3 Differentially Regulate the Proliferation and Survival of Developing Rat Brain Oligodendrocytes J. Neurosci., October 15, 1996; 16(20): 6433 - 6442. [Abstract] [Full Text] [PDF]